24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Opthamology
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:39
Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff
10:29
Intel VP: “We had 11 or 12 layers of management... now it’s 5 or 6”
21:48
From textile recycling to autonomous vessels: The vision behind the Dream Team startups
20:25
ELNET: German business leaders “are looking with admiration and respect towards the Startup Nation”
More stories
Buzz
Most popular
Daily
Weekly
1
Inside the mind of a Nobel physicist: John Martinis on the future of quantum computing
2
Check Point raises $1.75 billion, potentially eyeing AI expansion
3
Hapag-Lloyd eyes ZIM acquisition, workers push back
4
Sequoia’s Shaun Maguire says Israel risks losing “a war it can’t see”
5
Nice puts Actimize up for sale at a $1.5-2 billion price tag
More news
Opthamology
4 stories about Opthamology
How one female CEO overcame adversity to find a cure for Uveitis
04.02.22
|
Roni Dori
"I see us building a large company that will focus on the eye, beyond Uveitis. Our technology has tremendous potential to treat other diseases that cause blindness, and treat millions of patients," says Dr. Daphne Haim-Langford, who suffers from Uveitis and founded Tarsier Pharma
The Israeli startup treating the silent thief of sight
30.01.22
|
Yafit Ovadia
BELKIN Vision is using an automated laser procedure to tackle glaucoma, a disease that can lead to irreversible blindness
Ophthalmic Sciences unveils world's first AI contactless device for measuring eye fluid pressure
05.12.21
|
CTech
The device combines artificial intelligence in a virtual reality-like headset, enabling tele-diagnosis and monitoring for glaucoma. The company has begun steps toward FDA approval, and is raising funds to reach additional markets
BioLight to partner with Ichilov Medical Center to develop innovative ophthalmology technologies
29.11.21
|
CTech
According to the terms of the agreement, the company will retain the primary right to license technologies developed at Ichilov